ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620077; 2) Community: the network communities that were significantly associated with the response to NSC 620077; 3) Molecule: the relationships between components within communities and NSC 620077; 4) MDR: the compounds that were significantly associated with the NSC 620077.

NSC Compound Enrichment Correlation
NSC 736164 pyrazoline derivative 0.0339770934764508 0.16218143
NSC 742327 (3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone 0.0339770934764508 0.36817481
NSC 756304 GW678313X 0.0339770934764508 -0.11682411
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0339770934764508 0.36426109
NSC 127128 Null 0.0339770934764516 -0.2359912
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0339770934764516 0.357923
NSC 20200 [Diisobutyl(phenoxyethoxy)ethyl]dimethylbenzylammonium chloride 0.0339770934764516 0.11540886
NSC 237020 TA 1067 0.0339770934764516 0.39682241
NSC 290193 CYCLOSPORIN A 0.0339770934764516 0.43955163
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.0339770934764516 0.29267131
Total:108  Current:76    [First] [Prev] [Next] [Last]